Impact of Mavacamten Approval on Septal Reduction Therapy Rates in Hypertrophic Cardiomyopathy

Journal of the American Heart Association 2026 Open access

Read full text
Authors: Ramzi Ibrahim, Winston T. Wang, Hoang Nhat Pham, Mahmoud Abdelnabi, Steven J. Lester, Susan Wilansky, Hartzell Vernon Schaff, Jeffrey B. Geske, Reza Arsanjani, Chadi Ayoub
DOI: 10.1161/jaha.125.045649
Cited by: 1
References: 5

Fields of Study & Subjects

Cardiomyopathy and Myosin Studies Cardiac Structural Anomalies and Repair Cardiac pacing and defibrillation studies

Publication details

Journal / source
Journal of the American Heart Association
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
15
Issue
6
Pages
e045649–e045649
Publication date
4 March 2026
Language
EN